Webber Activ+ Extra fort
Natural health product licensed in Canada
- Other names
- Webber Activ+ Analgesic Cream Extra strength, Webber Activ+ Crème Analgésique Extra fort, Webber Activ+ Extra strength
- Licence holder
- J.L. Freeman SEC
- NPN or DIN-HM
- 80123398
- Status
- Active licence
- Licence date
- 6 March 2023
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| 1,8 cinéole Source : Eucalyptol | 2.5 % (p/p) |
| l-Menthol Source : l-Menthol | 4 % (p/p) |
| (E)-8-Méthyl-N-vanillyl-6-nonenamide Source : Capsaïcine | 0.05 % (p/p) |
| 2-hydroxybenzoate de méthyle Source : Salicylate de méthyle | 7.5 % (p/p) |
Non-medicinal ingredients
Alcool cétéarylique/Lauryl sulfate de sodium/Cétéaryl sulfate de sodium, Eau purifiée, Huile minérale légère, Vitamine E, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis. Used for the (temporary) relief of muscle and joint pain associated with rheumatoid arthritis or osteoarthritis, and pain of tendons and ligaments.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80123398
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.